The Japanese Biochemical Society/The Molecular Biology Society of Japan

11:01 AM - 11:27 AM

[3AW20-5] Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others

LOD 【E】

〇Kanaga Sabapathy1,2 (1.Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore, 2.Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore)

tumorigenesis、p53、dominant-negative、gain-of-function、therapeutic response

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password